Alexandra Sowa, author of The Ozempic Revolution, is a dual board-certied physician in internal and obesity medicine and the founder of SoWell, the go-to brand for GLP-1 users
However, it distinguishes itself by acting on two additional hormones: glucose-dependent insulinotropic polypeptide (GIP), which aids in blood sugar management, and glucagon, which can help suppress appetite and increase energy expenditure
High tides: Lillys $20bn spend, Amgen preps network to enter GLP-1 space Eli Lillys capital expenditure (CAPEX) has rocketed since 2020 to support blockbuster products Mounjaro and Zepbound
Tadalafil does not inhibit prostaglandins as do some agents for treating impotence (e.g., alprostadil)
On your first visit, Dr
It reported 28.7% average weight loss at 12 mg and 26.4% at 9 mg, compared with 2.1% for placebo